These CHIP-related mutations, particularly in genes such as DNMT3A, TET2, and ASXL1, can be inadvertently detected in plasma cfDNA and misattributed to the tumor, resulting in false-positive findings and erroneous clinical interpretations [109,110]. Here, ASXL1 is linked to neoplasm.